Prosecution Insights
Last updated: August 06, 2026

K&L Gates LLP - Chicago

6 pending office actions • 2 clients • 6 examiners • 3 art units • 0 of 6 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Quality Metrics (n=34052 apps, methodology: how we score firms)

84.7%
Allowance Rate
n=34052
+0.65σ
Allowance Rate (norm)
n=34052
3.8
OAs to Allowance
n=20482
+0.04σ
OAs to Allow (norm)
n=20482
1083 days
Time to Allowance
n=20482
+8.9pp
Interview Lift
n=34052
32.7%
RCE Rate
n=34052
2.8%
Appeal Rate
n=34052

Rejection Performance (% of received rejections ultimately overcome)

76.3%
§101 Overcome
n=2410
77.8%
§102 Overcome
n=8886
78.3%
§103 Overcome
n=15071
78.6%
§112 Overcome
n=10307

Specialization & Scale

A61K, G06F, H01M
Top CPC Subclasses
13%
Top-3 CPC Share
n=34052
88
Practitioners
n=34052
387.0
Apps / Practitioner
n=34052

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (83%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (67%)
§102 only1 (17%)
§112 only1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
50% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HULBERT, AMANDA K 1 84.5% +4.0%
LEVY, BRANDON WILLIAM 1 62.0% +48.1%
BASQUILL, SEAN M 1 38.8% +21.7%
TOTH, KAREN E 1 46.7% +25.4%
KIM, SAMUEL CHONG 1 48.5% +70.0%
EISEMAN, LYNSEY C 1 49.1% +39.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18953999 SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYE HULBERT, AMANDA K

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
13438705 CONTROLLED CROSS-LINKING INITIATION AND CORNEAL TOPOGRAPHY FEEDBACK SYSTEMS FOR DIRECTING CROSS-LINKING EISEMAN, LYNSEY C 20d
18913142 INSERTION SYSTEM FOR DELIVERY OF ACTIVE PHARMACEUTICAL AGENTS INSIDE THE EYE LEVY, BRANDON WILLIAM
18359642 OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF BASQUILL, SEAN M
17844497 INTRAOCULAR PHYSIOLOGICAL SENSOR TOTH, KAREN E
17128989 ON-DEMAND INTRAOCULAR PHYSIOLOGICAL SENSOR WITH TRABECULAR BYPASS FLOW KIM, SAMUEL CHONG

Client Portfolio (2 clients)

Client (Assignee)Pending OAs
GLAUKOS 4
Avedro 2

Top Art Units

Art UnitApps
37912
16141
37961

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18953999 SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYE Avedro, Inc. HULBERT, AMANDA K §102 Non-Final OA Pending Nov 20, 2024
18913142 INSERTION SYSTEM FOR DELIVERY OF ACTIVE PHARMACEUTICAL AGENTS INSIDE THE EYE Glaukos Corporation LEVY, BRANDON WILLIAM §103 Non-Final OA Pending Oct 11, 2024
18359642 OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF Glaukos Corporation BASQUILL, SEAN M 1614 §103 Non-Final OA Pending Jul 26, 2023
17844497 INTRAOCULAR PHYSIOLOGICAL SENSOR Glaukos Corporation TOTH, KAREN E 3791 §112 Final Rejection Pending Jun 20, 2022
17128989 ON-DEMAND INTRAOCULAR PHYSIOLOGICAL SENSOR WITH TRABECULAR BYPASS FLOW Glaukos Corporation KIM, SAMUEL CHONG 3791 §103 Final Rejection Pending Dec 21, 2020
13438705 CONTROLLED CROSS-LINKING INITIATION AND CORNEAL TOPOGRAPHY FEEDBACK SYSTEMS FOR DIRECTING CROSS-LINKING Avedro, Inc. EISEMAN, LYNSEY C 3796 §103 Non-Final OA 20d Pending Apr 03, 2012

Managing K&L Gates LLP - Chicago's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month